 |
|
Experimental Autoimmune Myasthenia Gravis in RatsModification by Thymectomy and Prednisolone
Donald B. Sanders, MD;
T. R. Johns, MD;
Mohyee E. Eldefrawi, PhD;
Edith E. Cobb
Arch Neurol. 1977;34(2):75-79.
Abstract
• In rats immunized with purified acetylcholine receptor protein (AChRP) from Torpedo electroplax, a defect of neuromuscular transmission physiologically identical to that seen in myasthenia gravis developed. The most sensitive index of the neuromuscular blockage was miniature end-plate potential (MEPP) amplitude. As early as 24 hours after inoculation with AChRP, the thymus showed reactive changes that are probably non-specific. Removal of the thymus before or within three days after immunization delayed, but did not prevent, development of reduced MEPP amplitude. Prednisolone given within 35 days after immunization produced reversal of MEPP reduction within 24 hours, but had no such immediate effect when given 15 days later. It is probable that prednisolone acted by reducing the immunologic responsiveness of the animals during the developing phase of the defect of neuromuscular transmission.
Author Affiliations
From the Department of Neurology and University of Virginia Jerry Lewis Neuromuscular Center, Charlottesville (Drs Sanders and Johns and Ms Cobb), and the Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore (Dr Eldefrawi).
Footnotes
Accepted for publication May 19, 1976.
Reprint requests to Department of Neurology, Box 147, University of Virginia Medical Center, Charlottesville, VA 22901 (Dr Sanders).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Myasthenia Gravis: A Clinical and Basic Science Review
Seybold
JAMA 1983;250:2516-2521.
ABSTRACT
Steroid Treatment for Experimental Autoimmune Myasthenia Gravis
Barone et al.
Arch Neurol 1980;37:663-666.
ABSTRACT
|
